ChRi Laboratories

Executive Summary

ChRi Laboratories is a Minnesota-based cannabis testing laboratory founded in 2019, offering ISO 17025-accredited and FDA-registered analytical services for recreational, medical, and hemp products. The company provides pharmaceutical-grade testing for potency, contaminants, and stability, ensuring product safety and regulatory compliance for cannabis operators across the Midwest. As a private company in the growing cannabis diagnostics sector, ChRi Laboratories is positioned to benefit from increasing demand for reliable testing as more states legalize cannabis and tighten regulatory requirements. However, the company faces competition from larger national labs and must navigate the evolving federal landscape. With a focus on quality and accreditation, ChRi Laboratories is well-suited for partnerships with cultivators, processors, and dispensaries seeking compliance and quality assurance. The company's location in a key cannabis market provides a solid foundation for growth, though scalability and technological upgrades will be critical to capturing market share in an increasingly commoditized testing environment.

Upcoming Catalysts (preview)

• TBDExpansion into New State Markets65% success
• TBDAdoption of Advanced Testing Technologies50% success
• 2026Potential Federal Cannabis Rescheduling Impact30% success